Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where David A. Goukassian is active.

Publication


Featured researches published by David A. Goukassian.


Nature Medicine | 2005

Sonic hedgehog myocardial gene therapy: tissue repair through transient reconstitution of embryonic signaling

Kengo Kusano; Roberto Pola; Toshinori Murayama; Cynthia Curry; Atsuhiko Kawamoto; Atsushi Iwakura; Satoshi Shintani; Masaaki; Jun Asai; Tengiz Tkebuchava; Tina Thorne; Hideya Takenaka; Ryuichi Aikawa; David A. Goukassian; Patrick von Samson; Hiromichi Hamada; Young-sup Yoon; Marcy Silver; Elizabeth Eaton; Hong Ma; Lindsay Heyd; Marianne Kearney; William Munger; Jeffery A Porter; Raj Kishore; Douglas W. Losordo

Sonic hedgehog (Shh) is a crucial regulator of organ development during embryogenesis. We investigated whether intramyocardial gene transfer of naked DNA encoding human Shh (phShh) could promote a favorable effect on recovery from acute and chronic myocardial ischemia in adult animals, not only by promoting neovascularization, but by broader effects, consistent with the role of this morphogen in embryogenesis. After Shh gene transfer, the hedgehog pathway was upregulated in mammalian fibroblasts and cardiomyocytes. This resulted in preservation of left ventricular function in both acute and chronic myocardial ischemia by enhanced neovascularization, and reduced fibrosis and cardiac apoptosis. Shh gene transfer also enhanced the contribution of bone marrow–derived endothelial progenitor cells to myocardial neovascularization. These data suggest that Shh gene therapy may have considerable therapeutic potential in individuals with acute and chronic myocardial ischemia by triggering expression of multiple trophic factors and engendering tissue repair in the adult heart.


The FASEB Journal | 2000

Mechanisms and implications of the age-associated decrease in DNA repair capacity

David A. Goukassian; Faten Gad; Mina Yaar; Mark S. Eller; Umbereen S. Nehal; Barbara A. Gilchrest

Skin cancer incidence is clearly linked to UV irradiation and increases exponentially with age. We studied the rate of removal of thymine dimers and (6–4) photoproducts in UV‐irradiated human dermal fibroblasts derived from donors of different ages. There was a significant decrease with aging in the repair rates of both thymine dimers and (6–4) photoproducts (P< 0.001). In addition, there was an age‐associated decrease in the protein levels of ERCC3, PCNA, RPA, XPA, and p53 that participate in nucleotide excision repair. Moreover, the mRNA levels of XPA, ERCC3, and PCNA were significantly reduced with aging, suggesting that these decreases are often regulated at the mRNA level. Furthermore, with age induction of p53 after UV irradiation was significantly reduced. Taken together, our data suggest that the age‐associated decrease in the repair of UV‐induced DNA damage results at least in part from decreased levels of proteins that participate in the repair process.—Goukassian, D., Gad, F., Yaar, M., Eller, M. S., Nehal, U. S., Gilchrest, B. A. Mechanisms and implications of the age‐associated decrease in DNA repair capacity. FASEB J. 14, 1325–1334 (2000)


The FASEB Journal | 2006

IL-10-induced TNF-alpha mRNA destabilization is mediated via IL-10 suppression of p38 MAP kinase activation and inhibition of HuR expression

Johnson Rajasingh; Evelyn Bord; Corinne Luedemann; Jun Asai; Hiromichi Hamada; Tina Thorne; Gangjian Qin; David A. Goukassian; Yan Zhu; Douglas W. Losordo; Raj Kishore

Inflammation plays an essential role in vascular injury and repair. Mononuclear phagocytes are important contributors in these processes, in part, via adhesive interactions and secretion of proinflammatory cytokines. The antiinflammatory cytokine interleukin (IL)‐10 suppresses such responses via deactivation of monocytes/macrophages and repression of inflammatory cytokine expression. The mechanisms of IL‐10s suppressive action are, however, incompletely characterized. Here, we report that systemic IL‐10 treatment after carotid artery denudation in mice blunts inflammatory cell infiltration and arterial tumor necrosis factor (TNF) expression. At the molecular level, in a human monocytic cell line, U937 IL‐10 suppressed LPS‐induced mRNA expression of a number of inflammatory cytokines, mainly via posttranscriptional mRNA destabilization. Detailed studies on IL‐10 regulation of TNF‐ mRNA expression identified AU‐rich elements (ARE) in the 3 untranslated region as a necessary determinant of IL‐10mediated TNF‐α mRNA destabilization. IL‐10 sensitivity to TNF depends on the ability of IL‐10 to inhibit the expression and mRNA‐stabilizing protein HuR and via IL‐10 mediated repression of p38 mitogen‐activated protein (MAP) kinase activation. Because IL‐10 function and signaling are important components for control of inflammatory responses, these results may provide insights necessary to develop strategies for modulating vascular repair and other accelerated arteriopathies, including transplant vasculopathy and vein graft hyperplasia.—Johnson Rajasingh, Evelyn Bord, Corinne Luedemann, Jun Asai, Hiromichi Hamada, Tina Thorne, Gangjian Qin, David Goukassian, Yan Zhu, Douglas W. Losordo, and Raj Kishore. IL‐10‐induced TNF‐αalpha mRNA destabilization is mediated via IL‐10 suppression of p38 MAP kinase activation and inhibition of HuR expression. FASEB J. 20, E1393–E1403 (2006)


Journal of Experimental Medicine | 2006

Functional disruption of α4 integrin mobilizes bone marrow-derived endothelial progenitors and augments ischemic neovascularization

Gangjian Qin; Masaaki; Marcy Silver; Andrea Wecker; Evelyn Bord; Hong Ma; Mary Gavin; David A. Goukassian; Young-sup Yoon; Thalia Papayannopoulou; Takayuki Asahara; Marianne Kearney; Tina Thorne; Cynthia Curry; Liz Eaton; Lindsay Heyd; Deepika Dinesh; Raj Kishore; Yan Zhu; Douglas W. Losordo

The cell surface receptor α4 integrin plays a critical role in the homing, engraftment, and maintenance of hematopoietic progenitor cells (HPCs) in the bone marrow (BM). Down-regulation or functional blockade of α4 integrin or its ligand vascular cell adhesion molecule-1 mobilizes long-term HPCs. We investigated the role of α4 integrin in the mobilization and homing of BM endothelial progenitor cells (EPCs). EPCs with endothelial colony-forming activity in the BM are exclusively α4 integrin–expressing cells. In vivo, a single dose of anti–α4 integrin antibody resulted in increased circulating EPC counts for 3 d. In hindlimb ischemia and myocardial infarction, systemically administered anti–α4 integrin antibody increased recruitment and incorporation of BM EPCs in newly formed vasculature and improved functional blood flow recovery and tissue preservation. Interestingly, BM EPCs that had been preblocked with anti–α4 integrin ex vivo or collected from α4 integrin–deficient mice incorporated as well as control cells into the neovasculature in ischemic sites, suggesting that α4 integrin may be dispensable or play a redundant role in EPC homing to ischemic tissue. These data indicate that functional disruption of α4 integrin may represent a potential angiogenic therapy for ischemic disease by increasing the available circulating supply of EPCs.


The FASEB Journal | 2001

Overexpression of p27Kip1 by doxycycline-regulated adenoviral vectors inhibits endothelial cell proliferation and migration and impairs angiogenesis

David A. Goukassian; Antonio Díez-Juan; Takayuki Asahara; Peter Schratzberger; Marcy Silver; Toshinori Murayama; Jeffrey M. Isner; Vicente Andrés

Formation of new blood vessels in the adult animal (i.e., angiogenesis) is an important event for tissue repair and for tumor growth and metastasis. Angiogenesis involves the migration and proliferation of endothelial cells. We have investigated the role of the growth suppressor p27Kip1 (p27) on endothelial cell function in vitro and angiogenesis in vivo. We have generated Ad‐TetON, a replication‐deficient adenovi‐rus that constitutively expresses the reverse tet‐respon‐sive transcriptional activator, and Ad‐TRE‐p27, which drives expression of p27 under the control of the tet response element. Western blot analysis demonstrated doxycycline‐dependent overexpression of p27 in human umbilical vein endothelial cells (HUVECs) coinfected with Ad‐TetON and Ad‐TRE‐p27, which resulted in a marked inhibition of DNA replication and cell migration in vitro. Inducible overexpression of p27 in cultured HUVECs inhibited the formation of tubelike structures and, when applied in a murine model of hind limb ischemia, reduced hind limb blood flow recovery and capillary density. These findings thus underscore a novel role of p27 in regulating endothelial cell migration in vitro and angiogenesis in vivo, suggesting a novel anti‐angiogenic therapy based on inducible p27 overexpression.


Circulation | 2007

Tumor necrosis factor-α receptor p75 is required in ischemia-induced neovascularization

David A. Goukassian; Gangjian Qin; Christine Dolan; Toshinori Murayama; Marcy Silver; Cynthia Curry; Elizabeth Eaton; Corinne Luedemann; Hong Ma; Takayuki Asahara; Victor Zak; Shanu Mehta; Aaron Burg; Tina Thorne; Raj Kishore; Douglas W. Losordo

Background— Aging is a risk factor for coronary and peripheral artery disease. Tumor necrosis factor-α (TNF-α), a proinflammatory cytokine, is expressed in ischemic tissue and is known to modulate angiogenesis. Little is known about the role of TNF-α receptors (TNFR1/p55 and TNFR2/p75) in angiogenic signaling. Methods and Results— We studied neovascularization in the hindlimb ischemia model in young and old TNFR2/p75 knockout (p75KO) and wild-type age-matched controls. Between days 7 to 10 after hindlimb surgery, 100% of old p75KOs experienced autoamputation of the operated limbs, whereas none of the age-matched wild-type mice exhibited hindlimb necrosis. Poor blood flow recovery in p75KO mice was associated with increased endothelial cell apoptosis, decreased capillary density, and significant reductions in the expression of vascular endothelial growth factor and basic fibroblast growth factor-2 mRNA transcripts in ischemic tissue and in circulating endothelial progenitor cells. The number of circulating bone marrow–derived endothelial progenitor cells was significantly reduced in p75KO mice. Transplantation of wild-type bone marrow mononuclear cells into irradiated old p75KO mice 1 month before hindlimb surgery prevented limb loss. Conclusions— Our present study suggests that ischemia-induced endothelial progenitor cell–mediated neovascularization is dependent, at least in part, on p75 TNF receptor expressed in bone marrow–derived cells. Specifically, endothelial cell/endothelial progenitor cell survival, vascular endothelial growth factor expression, endothelial progenitor cell mobilization from bone marrow, endothelial progenitor cell differentiation, and ultimately ischemia-induced collateral vessel development are dependent on signaling through TNFR2/p75. Furthermore, because TNFR2/p75 becomes an age-related limiting factor in postischemic recovery, it may be a potential gene target for therapeutic interventions in adult vascular diseases.


Clinical and Experimental Immunology | 2008

Ageing is associated with diminished apoptotic cell clearance in vivo

Tamar Aprahamian; Y. Takemura; David A. Goukassian; Kenneth Walsh

Ageing leads to immune system dysfunction and the accumulation of autoantibodies. Because the rapid phagocytic clearance of apoptotic cells is required to prevent the development of autoimmunity, we examined the relative clearance of apoptotic material in young and aged mice using two independent assays. First, 2‐year‐old mice were found to be impaired in their ability to clear apoptotic keratinocytes following ultraviolet irradiation of the skin. Secondly, peritoneal macrophages exposed to apoptotic Jurkat T cells in vivo displayed diminished phagocytic activity in aged mice compared with 8‐week‐old mice. Consistent with these findings, aged mice exhibited signs of autoimmunity with the appearance of anti‐nuclear antibodies and increased kidney glomerular size as well as complement deposits within the glomeruli. In vitro assays revealed that the pretreatment of macrophages with the serum from aged mice led to a reduction in their ability to phagocytose apoptotic bodies compared with macrophages treated with serum from young mice. These data show that the ageing process is accompanied by a diminished ability to clear apoptotic debris. This accumulation of apoptotic debris could contribute to immune system dysfunction that occurs in aged organisms.


The FASEB Journal | 2006

T-oligos augment UV-induced protective responses in human skin

Simin Arad; David A. Goukassian; Barbara A. Gilchrest

We have shown that DNA oligonucleotides substantially homologous to the telomere 3‐prime overhang sequence (T‐oligos) increase DNA repair capacity (DRC) in cultured human cells and decrease UV‐induced mutation rate and photocarcinogenesis in mouse skin. To investigate the protective effects of T‐oligos in intact human skin, paired skin explants obtained from adult donors were treated with T‐oligos or diluent alone for 24 h, then UVB‐ or sham‐irradiated, and processed after 6, 24, 48, 72, and 96 h for histological analysis. After UV irradiation apoptotic epidermal cells were comparable in diluent‐ and T‐oligo‐treated skin. Proliferating (Ki67+) cells were sparse in sham‐irradiated skin and for 24 h after UV in both diluent‐ and T‐oligo‐treated specimens. However, compared to diluent controls, at 48 and 72 h T‐oligos significantly inhibited UV‐induced rebound hyperproliferation. Maximum and comparable cyclobutane pyrimidine dimers (CPDs) were detected immediately after UV irradiation in diluent‐ and T‐oligo‐treated skin, but CPDs were strikingly reduced in T‐oligo‐ vs. diluent‐treated skin at 24, 48, and 72 h. Total and activated p53 protein was increased in T‐oligo‐ vs. diluent‐pretreated skin at the time of irradiation, and up to 3‐fold increases persisted for 24 h post‐UV. Over 5 days, UV irradiation and T‐oligo comparably increased expression of melanogenic proteins and each increased epidermal melanin content 3‐ to 5‐fold, with distinct nuclear capping in many keratinocytes. In combination, these findings predict that T‐oligo treatment will increase melanogenesis, prolong epidermal arrest, and increase DNA repair rate after UV irradiation, thus decreasing the severity of acute and chronic photodamage in human skin. Moreover, the data document an inducible SOS‐like response consisting of increased melanogenesis and increased DNA repair capacity in human skin following UV‐induced damage that is also produced by T‐oligos in the absence of initial damage.—Arad, S., Konnikov, N., Goukassian, D. A., Gilchrest, B. A. T‐oligos augment UV‐induced protective responses in human skin. FASEB J. 20, E1237‐E1247 (2006)


Skin Pharmacology and Physiology | 2007

Dietary lutein/zeaxanthin partially reduces photoaging and photocarcinogenesis in chronically UVB-irradiated Skh-1 hairless mice.

S. Astner; A. Wu; J. Chen; N. Philips; Francisca Rius-Díaz; Concepción Parrado; Martin C. Mihm; David A. Goukassian; Madhu A. Pathak; Salvador González

Lutein and zeaxanthin are xanthophyll carotenoids with potent antioxidant properties protecting the skin from acute photodamage. This study extended the investigation to chronic photodamage and photocarcinogenesis. Mice received either a lutein/zeaxanthin-supplemented diet or a standard nonsupplemented diet. Dorsal skin of female Skh-1 hairless mice was exposed to UVB radiation with a cumulative dose of 16,000 mJ/cm2 for photoaging and 30,200 mJ/cm2 for photocarcinogenesis. Clinical evaluations were performed weekly, and the animals were sacrificed 24 h after the last UVB exposure. For photoaging experiments, skin fold thickness, suprapapillary plate thickness, mast cell counts and dermal desmosine content were evaluated. For photocarcinogenesis, samples of tumors larger than 2 mm were analyzed for histological characterization, hyperproliferation index, tumor multiplicity, total tumor volume and tumor-free survival time. Results of the photoaging experiment revealed that skin fold thickness and number of infiltrating mast cells following UVB irradiation were significantly less in lutein/zeaxanthin-treated mice when compared to irradiated animals fed the standard diet. The results of the photocarcinogenesis experiment were increased tumor-free survival time, reduced tumor multiplicity and total tumor volume in lutein/zeaxanthin-treated mice in comparison with control irradiated animals fed the standard diet. These data demonstrate that dietary lutein/zeaxanthin supplementation protects the skin against UVB-induced photoaging and photocarcinogenesis.


PLOS ONE | 2013

Rosuvastatin Enhances Angiogenesis via eNOS-Dependent Mobilization of Endothelial Progenitor Cells

Junlan Zhou; Min Cheng; Yu Hua Liao; Yu Hu; Min Wu; Wang Q; Bo Qin; Hong Wang; Yan Zhu; Xiu Mei Gao; David A. Goukassian; Ting C. Zhao; Yao Liang Tang; Raj Kishore; Gangjian Qin

Circulating endothelial progenitor cells (circEPCs) of bone marrow (BM) origin contribute to postnatal neovascularization and represent a potential therapeutic target for ischemic disease. Statins are beneficial for ischemia disease and have been implicated to increase neovascularization via mechanisms independent of lipid lowering. However, the effect of Statins on EPC function is not completely understood. Here we sought to investigate the effects of Rosuvastatin (Ros) on EPC mobilization and EPC-mediated neovascularization during ischemic injury. In a mouse model of surgically-induced hindlimb ischemia (HLI), treatment of mice with low dose (0.1 mg/kg) but not high dose (5 mg/kg) significantly increased capillary density and accelerated blood flow recovery, as compared to saline-treated group. When HLI was induced in mice that had received Tie2/LacZ BM transplantation, Ros treatment led a significantly larger amount of endothelial cells (ECs) of BM origin incorporated at ischemic sites than saline. After treatment of mice with a single low dose of Ros, circEPCs significantly increased from 2 h, peaked at 4 h, declined until 8 h. In a growth-factor reduced Matrigel plug-in assay, Ros treatment for 5 d induced endothelial lineage differentiation in vivo. Interestingly, the enhanced circEPCs and post-HLI neovascularization stimulated by Ros were blunted in mice deficient in endothelial nitric oxide synthase (eNOS), and Ros increased p-Akt/p-eNOS levels in EPCs in vitro, indicating these effects of Ros are dependent on eNOS activity. We conclude that Ros increases circEPCs and promotes their de novo differentiation through eNOS pathway.

Collaboration


Dive into the David A. Goukassian's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Juyong Lee

University of Connecticut Health Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gangjian Qin

Northwestern University

View shared research outputs
Top Co-Authors

Avatar

James P. Morgan

Prince Henry's Institute of Medical Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge